Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Wha Kim

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2016
Construction of a database for published phase II/III drug intervention clinical trials for the period 2009-2014 comprising 2,326 records, 90 disease categories, and 939 drug entitiesSohyun Jeong, Nayoung Han, Boyoon Choi, et al.
Scientific Reports|December 26, 2018
Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patientsMinji Sohn, Myeong Gyu Kim, Nayoung Han, et al.
Scientific Reports|February 9, 2020
Author Correction: Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patientsMinji Sohn, Myeong Gyu Kim, Nayoung Han, et al.
Cancer Research|November 17, 2007
Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistanceZhi Shi, Xing-Xiang Peng, In-Wha Kim, et al.
Trials|June 23, 2017
Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013Sohyun Jeong, Minji Sohn, Jae Hyun Kim, et al.
Cancer Research|March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistanceZhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2018
Network analysis of drug-related problems in hospitalized patients with hematologic malignanciesMyeong Gyu Kim, Chae Reen Jeong, Hyun Jee Kim, et al.
Journal of Gastroenterology and Hepatology|November 3, 2010
Western-style diets induce macrophage infiltration and contribute to colitis-associated carcinogenesisIn-Wha Kim, Seung-Jae Myung, Mi Young Do, et al.
Biochemical Pharmacology|December 9, 2008
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Cancer Investigation|April 8, 2011
15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancerHo June Song, Seung-Jae Myung, In-Wha Kim, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2016
Construction of a database for published phase II/III drug intervention clinical trials for the period 2009-2014 comprising 2,326 records, 90 disease categories, and 939 drug entitiesSohyun Jeong, Nayoung Han, Boyoon Choi, et al.
Scientific Reports|December 26, 2018
Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patientsMinji Sohn, Myeong Gyu Kim, Nayoung Han, et al.
Scientific Reports|February 9, 2020
Author Correction: Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patientsMinji Sohn, Myeong Gyu Kim, Nayoung Han, et al.
Cancer Research|November 17, 2007
Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistanceZhi Shi, Xing-Xiang Peng, In-Wha Kim, et al.
Trials|June 23, 2017
Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013Sohyun Jeong, Minji Sohn, Jae Hyun Kim, et al.
Cancer Research|March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistanceZhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2018
Network analysis of drug-related problems in hospitalized patients with hematologic malignanciesMyeong Gyu Kim, Chae Reen Jeong, Hyun Jee Kim, et al.
Journal of Gastroenterology and Hepatology|November 3, 2010
Western-style diets induce macrophage infiltration and contribute to colitis-associated carcinogenesisIn-Wha Kim, Seung-Jae Myung, Mi Young Do, et al.
Biochemical Pharmacology|December 9, 2008
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Cancer Investigation|April 8, 2011
15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancerHo June Song, Seung-Jae Myung, In-Wha Kim, et al.
Pageof 11